Agile Therapeutics Announces Presentation of Safety and Efficacy Data of Twirla® (Levonorgestrel and Ethinyl Estradiol) Transdermal System in Women of Differing BMI Categories at ACOG Annual Meeting
PRINCETON, N.J., April 30, 2021 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare…
Trust Stamp announces allowance by the United States Patent and Trademark Office (“USPTO”) of a Non-Provisional Patent Application in respect of technology designed to identify deep fake and other Generative AI fuelled attacks in identity authentication processes
Global Media First Drive of G700: A Comprehensive Validation of GAIA Hybrid Off-Road Architecture
Scandium International Mining Announces Exercise of Options by Chief Executive Officer and Chief Financial Officer